TIAP Voices: Why Canadian Digital Health Companies Must Think Globally By: Mobeen Lalani, TIAP Manager, Technology and Venture Development Canadian digital health, artificial intelligence (AI), and medical device companies have long…
A new partnership by MaRS, OBIO® and TIAP aims to help ventures scale faster, attract capital and deliver breakthrough health innovations to the world. TORONTO, October 27, 2025 –…
TIAP Launches Next Generation Program to Support Early-Stage Drug Development LAB150-NextGen to offer up to $1.6M USD per project to advance new drug candidatesMay 20, 2025Building on the success of…
TIAP Voices: The Venture Building Journey and the Importance of Balanced Investor Engagement by: Mobeen Lalani, TIAP Senior Analyst, Technology and Venture Development In today’s ever-evolving health innovation and business…
Government of Canada invests in southern Ontario’s life sciences sector From: Federal Economic Development Agency for Southern Ontario News release Six life sciences organizations expand manufacturing capabilities and commercialize innovations February…
Grey Matter Neurosciences Secures License for World-Leading Focused Ultrasound Technology from Sunnybrook Research Institute, Announces $14 Million Financing to Advance Treatment for Alzheimer's Disease News provided by Grey Matter Neurosciences …
Myant Accelerates Precision Healthcare with Acquisition of Bitnobi Inc. USA - English News provided by Myant Corp. Jan 16, 2025, 10:55 ET TORONTO, Jan. 16, 2025 /PRNewswire/ -- Myant, a global leader…
TIAP FEATURES: Critical Technologies From Sunnybrook Research Institute Powering Advances In Therapeutic Ultrasound Catheters TIAP’s Critical Technologies Program continues to gather steam with the latest initiative to receive support…
TIAP Voices: From Insight to Innovation — Ensuring Your Discovery Process Includes Discovering Your Customer By: Mobeen Lalani, TIAP Senior Analyst, Technology and Venture Development In the dynamic world of…
Radiant Bio Closes $35 Million Series A Financing to Advance Therapeutic Pipeline with Its Proprietary Multabody™ Platform Funding co-led by the Bill & Melinda Gates Foundation and Amplitude Ventures to…